Welcome to our dedicated page for GOLDEN DEVELOPING SOL news (Ticker: DVLP), a resource for investors and traders seeking the latest updates and insights on GOLDEN DEVELOPING SOL stock.
Golden Developing Solutions Inc. (DVLP) is a commercial real estate investment firm that recently disclosed a voluntary Chapter 11 bankruptcy filing to address creditor issues. The company has investments in three pharmacies, with one fully operational and plans for the others to be operational by 2023. Through strategic moves, DVLP aims to protect shareholder equity and execute sales and marketing strategies efficiently.
With a focus on delivering specialty medicine with rapid delivery services in the U.S., DVLP recently acquired three specialty pharmacies, expanding its service offerings to states like Michigan and Florida. These acquisitions have bolstered the company's revenue capacity to $100M, positioning DVLP to set high standards in service, reliability, and safety in the health and wellness industry.
Golden Developing Solutions Inc. (OTC Pink:DVLP) announced December 2022 sales exceeded $5.6 million, despite challenges in onboarding its largest customer. Anticipating a 35-40% revenue increase upon completion of onboarding, the company is focused on transitioning from four recent acquisitions in the specialty pharmacy sector. A temporary dip in Q1 sales is expected, but a robust rebound is forecasted as transitions finalize. The CEO highlighted the company's strategy to continue acquisitions in 2023, positioning for growth in a promising health and wellness market.
Golden Developing Solutions Inc. (OTC PINK:DVLP) has successfully completed the conversion of 320 million shares of common stock into 320,000 shares of preferred stock, significantly reducing the number of common shares in circulation. This strategic move, announced previously in November, aligns with the company's roll-up strategy in the specialty pharmacy sector following multiple acquisitions. The company aims to enhance shareholder value and has projected consolidated revenue of $100 million from its recent specialty pharmacy acquisitions in Michigan and Florida. Management will provide further details on upcoming acquisitions soon.
DVLP, a health and wellness holding company, announced its CEO, Stavros Triant, will appear in interviews on Fox Business, Bloomberg TV, and Newsmax TV. The interviews will cover the company's focus on the specialty pharmacy marketplace, discussing its growth strategy through acquisitions in this sector. DVLP has completed four acquisitions in 2022, generating a consolidated revenue of $100M. Triant aims to drive company success with a robust pipeline of potential acquisitions and investments to enhance infrastructure for future growth.
Golden Developing Solutions Inc. (OTC Pink: DVLP) announced an upcoming interview for CEO Stavros Triant on the Stock Day Podcast on December 14, 2022. The discussion will focus on the company’s growth, highlighted by four completed acquisitions in the Pharmacy and Wellness sector and plans for two additional acquisitions, targeting $106 million in annualized revenues alongside an estimated $100 million in projected revenue. This initiative reflects the company’s strategy to enhance transparency and outreach to shareholders through various media platforms.
Golden Developing Solutions (OTC Pink:DVLP) announced an interview with CEO Stavros Triant on FMW Media's 'New To The Street', set to air on December 7, 2022. The discussion will focus on the company's recent acquisitions in the Pharmacy and Wellness sectors, emphasizing its plans for aggressive expansion and increased market share in specialty pharmacy services. The company recently completed its 3rd and 4th acquisitions, with more in the pipeline, targeting annualized revenues of $106 million. The recent acquisition efforts significantly enhance the company's service capabilities in Florida and Michigan.
Golden Developing Solutions (OTC Pink: DVLP) has recently completed four acquisitions in the specialty pharmacy sector, projecting excess revenues of $100M per year. The company is poised to finalize two additional acquisitions, potentially doubling previous revenue estimates to $206M. Management emphasizes their commitment to creating shareholder value and expanding their market presence in health and wellness. With plans to enhance transparency and communications, Golden Developing Solutions aims for significant growth in the coming years.
Golden Developing Solutions (OTC PINK:DVLP) announced the conversion of 320 million shares of common stock owned by CEO Stavros Triant into 320,000 shares of preferred stock, effectively reducing the publicly traded common shares. This strategic move aims to strengthen the company's relationship with investors in the specialty pharmacy space, where it has been active in acquiring companies. The firm is finalizing another acquisition with projected revenues of $106 million. Their consolidated revenue has reached $100 million following four acquisitions in 2022, enhancing their service capabilities in Michigan and Florida.
Golden Developing Solutions Inc. (OTC PINK:DVLP) has completed its 3rd and 4th acquisitions, acquiring Bushnell Pharmacy and Sai Siva Healthcare for a total of $5.3 million. The company projects revenues exceeding $100 million annually from these acquisitions.
Stavros Triant, CEO, emphasized expected revenue growth and outlined prior acquisitions completed in September 2022, with the latest transactions enhancing the company's pharmaceutical delivery capabilities in Florida and Michigan.
Golden Developing Solutions Inc. (OTC Pink: DVLP) has executed a Letter of Intent (LOI) for its next acquisition, which will significantly enhance its operational scale by more than doubling its size. This strategic move is expected to integrate an important logistical revenue-producing asset into the company, further positioning DVLP in the Health and Wellness sector. CEO Stavros Triant expressed optimism about the ongoing journey and growth potential.
FAQ
What is the market cap of GOLDEN DEVELOPING SOL (DVLP)?
What is Golden Developing Solutions Inc. (DVLP)?
What recent disclosure did DVLP make?
How many pharmacies does DVLP have investments in?
What are DVLP's recent acquisitions?
What is the revenue capacity of DVLP after the recent acquisitions?
What standards does DVLP aim to set in the industry?
What key focus does DVLP have in delivering specialty medicine?
Who is the CEO of Golden Developing Solutions Inc. (DVLP)?
How can shareholders engage with DVLP?
What strategic moves is DVLP making to protect shareholder equity?
